Page last updated: 2024-09-02

morpholinoanthracycline mx2 and irinotecan

morpholinoanthracycline mx2 has been researched along with irinotecan in 1 studies

Compound Research Comparison

Studies
(morpholinoanthracycline mx2)
Trials
(morpholinoanthracycline mx2)
Recent Studies (post-2010)
(morpholinoanthracycline mx2)
Studies
(irinotecan)
Trials
(irinotecan)
Recent Studies (post-2010) (irinotecan)
531508,0021,8853,752

Protein Interaction Comparison

ProteinTaxonomymorpholinoanthracycline mx2 (IC50)irinotecan (IC50)
Solute carrier family 22 member 2Homo sapiens (human)2.7
Interstitial collagenaseHomo sapiens (human)6.06
Muscarinic acetylcholine receptor M4Homo sapiens (human)1.556
Alpha-2C adrenergic receptorHomo sapiens (human)3.171
AcetylcholinesteraseHomo sapiens (human)1.827
Multidrug and toxin extrusion protein 2Homo sapiens (human)7.9
Multidrug and toxin extrusion protein 1Homo sapiens (human)4.7667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohnishi, K; Ohno, R1

Reviews

1 review(s) available for morpholinoanthracycline mx2 and irinotecan

ArticleYear
[New antitumor drugs for malignant lymphoma: a review].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:8

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carubicin; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Piperazines

1994